These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18363897)

  • 1. Review article: current management of metastatic colorectal cancer - the evolving impact of targeted drug therapies.
    Yau T; Chan P; Ching Chan Y; Wong BC; Liang R; Epstein RJ
    Aliment Pharmacol Ther; 2008 Jun; 27(11):997-1005. PubMed ID: 18363897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy for colorectal cancer--an overview of current management for surgeons.
    Lawes D; Taylor I
    Eur J Surg Oncol; 2005 Nov; 31(9):932-41. PubMed ID: 15979268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
    Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
    Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life versus prolongation of life in patients treated with chemotherapy in advanced colorectal cancer: A review of randomized controlled clinical trials.
    de Kort SJ; Willemse PH; Habraken JM; de Haes HC; Willems DL; Richel DJ
    Eur J Cancer; 2006 May; 42(7):835-45. PubMed ID: 16481158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.
    Benoist S; Nordlinger B
    Ann Surg Oncol; 2009 Sep; 16(9):2385-90. PubMed ID: 19554377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating targeted agents into therapeutic regimens for patients with resectable colorectal cancer.
    Marshall JL
    Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S63-6. PubMed ID: 19064409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials.
    O'Neil BH; Goldberg RM
    Oncologist; 2008 Oct; 13(10):1074-83. PubMed ID: 18922828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent therapy in the palliative treatment of metastatic colorectal cancer.
    Wadhawan A; Stephens R; Adams R
    Expert Rev Anticancer Ther; 2009 Jan; 9(1):125-34. PubMed ID: 19105712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cost-effectiveness analysis of different chemotherapeutical regimens in metastatic colorectal cancer].
    Liu TS; Yu YY; Chen YY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar; 11(2):120-3. PubMed ID: 18344076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The continuum of care: a paradigm for the management of metastatic colorectal cancer.
    Goldberg RM; Rothenberg ML; Van Cutsem E; Benson AB; Blanke CD; Diasio RB; Grothey A; Lenz HJ; Meropol NJ; Ramanathan RK; Becerra CH; Wickham R; Armstrong D; Viele C
    Oncologist; 2007 Jan; 12(1):38-50. PubMed ID: 17227899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updated options for liver-limited metastatic colorectal cancer.
    Alberts SR
    Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S58-62. PubMed ID: 19064408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy for recurrent and metastatic cervical cancer.
    Tao X; Hu W; Ramirez PT; Kavanagh JJ
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S67-71. PubMed ID: 18533239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical review of the full economic evaluations of pharmacological treatments for colorectal cancer.
    Garattini L; Compadri PD; Koleva D; Pasina L; Nobili A
    J Med Econ; 2008; 11(1):177-97. PubMed ID: 19450119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancer.
    Bouchahda M; Adam R; Giacchetti S; Castaing D; Brezault-Bonnet C; Hauteville D; Innominato PF; Focan C; Machover D; Lévi F
    Cancer; 2009 Nov; 115(21):4990-9. PubMed ID: 19637365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Markov model assessing the effectiveness and cost-effectiveness of FOLFOX compared with FOLFIRI for the initial treatment of metastatic colorectal cancer.
    Tumeh JW; Shenoy PJ; Moore SG; Kauh J; Flowers C
    Am J Clin Oncol; 2009 Feb; 32(1):49-55. PubMed ID: 19194125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy for colorectal cancer liver metastases.
    Alberts SR; Wagman LD
    Oncologist; 2008 Oct; 13(10):1063-73. PubMed ID: 18838438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy for metastatic colorectal cancer].
    Iwasa S; Shimada Y
    Gan To Kagaku Ryoho; 2008 Sep; 35(9):1467-74. PubMed ID: 18799899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimum use of biologics and role of maintenance therapy in colon cancer.
    Marshall J
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S33-5. PubMed ID: 17178283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General principles of chemotherapy.
    Ricevuto E; Bruera G; Marchetti P
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):269-71. PubMed ID: 20496534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in targeted therapies for colorectal cancer.
    Milano M; Guerin O
    J Oncol Pharm Pract; 2006 Jun; 12(2):69-73. PubMed ID: 16984744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.